These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8900933)

  • 21. Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simian immunodeficiency virus Gag protein induces long-lasting, antigen-specific immune responses in guinea pigs.
    Kawahara M; Matsuo K; Honda M
    Clin Immunol; 2006 Apr; 119(1):67-78. PubMed ID: 16386958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Independence of the delayed hypersensitivity response from protection against Leishmania mexicana pifanoi].
    Pérez HA; De la Rora M
    Acta Cient Venez; 1986; 37(5):542-6. PubMed ID: 2966535
    [No Abstract]   [Full Text] [Related]  

  • 23. Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB/c mice.
    Jaafari MR; Ghafarian A; Farrokh-Gisour A; Samiei A; Kheiri MT; Mahboudi F; Barkhordari F; Khamesipour A; McMaster WR
    Vaccine; 2006 Jul; 24(29-30):5708-17. PubMed ID: 16740346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early production of IL-4 and induction of Th2 responses in the lymph node originate from an MHC class I-independent CD4+NK1.1- T cell population.
    von der Weid T; Beebe AM; Roopenian DC; Coffman RL
    J Immunol; 1996 Nov; 157(10):4421-7. PubMed ID: 8906817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Characteristics of T-suppressors responsible for the competition between cellular and humoral immune response in the spleen].
    Gusev EIu; Kevorkov NN
    Biull Eksp Biol Med; 1993 Mar; 115(3):287-9. PubMed ID: 8054627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis.
    Calvopina M; Barroso PA; Marco JD; Korenaga M; Cooper PJ; Nonaka S; Hashiguchi Y
    Vaccine; 2006 Jul; 24(27-28):5645-52. PubMed ID: 16621179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosal inoculation of Lactobacillus expressing hCGbeta induces an anti-hCGbeta antibody response in mice of different strains.
    Yao XY; Yuan MM; Li DJ
    Methods; 2006 Feb; 38(2):124-32. PubMed ID: 16414267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Membrane lymphotoxin contributes to anti-leishmanial immunity by controlling structural integrity of lymphoid organs.
    Wilhelm P; Riminton DS; Ritter U; Lemckert FA; Scheidig C; Hoek R; Sedgwick JD; Körner H
    Eur J Immunol; 2002 Jul; 32(7):1993-2003. PubMed ID: 12115620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients.
    Rafati S; Gholami E; Hassani N; Ghaemimanesh F; Taslimi Y; Taheri T; Soong L
    Vaccine; 2007 May; 25(21):4159-69. PubMed ID: 17395340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis.
    Sjölander A; Baldwin TM; Curtis JM; Handman E
    J Immunol; 1998 Apr; 160(8):3949-57. PubMed ID: 9558102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4+, CD8+ and CD4- CD8- T cell-subsets can confer protection against Leishmania m. mexicana infection.
    Lezama-Dávila CM; Gallagher G
    Mem Inst Oswaldo Cruz; 1995; 90(1):51-8. PubMed ID: 8524085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of Fab-fragments of antibodies against spleen cell surface antigens on the development of antibody formation in cultures of different densities].
    Korukova AA; Kim AB; Grigor'eva OS; Gurvich AE
    Biull Eksp Biol Med; 1984 Mar; 97(3):315-7. PubMed ID: 6704524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of Bacillus megaterium H on the immune response to heterologous antigen in mice].
    Zatula DG; Lisovenko GS; Siadro TA
    Mikrobiol Zh (1978); 1986; 48(1):77-81. PubMed ID: 3151913
    [No Abstract]   [Full Text] [Related]  

  • 34. Leishmania mexicana in C3H mice: BCG and levamisole treatment of established infections.
    Grimaldi GF; Moriearty PL; Hoff R
    Clin Exp Immunol; 1980 Aug; 41(2):237-42. PubMed ID: 7438553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection.
    Howard JG; Nicklin S; Hale C; Liew FY
    J Immunol; 1982 Nov; 129(5):2206-12. PubMed ID: 7119442
    [No Abstract]   [Full Text] [Related]  

  • 36. Delayed type hypersensitivity to mycobacterial antigens without protective immunity: a failure to produce the right specificity or the right type of immune reaction?
    Løvik M; Closs O
    Scand J Infect Dis Suppl; 1980; Suppl 24():224-7. PubMed ID: 7010561
    [No Abstract]   [Full Text] [Related]  

  • 37. Leishmania major: common antigen responsible for induction of delayed-type hypersensitivity response in guinea pigs.
    Khabiri AR; Bagheri F; Assmar M
    Parasitol Res; 2007 Feb; 100(3):629-32. PubMed ID: 17013648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination of mice against Leishmania mexicana amazonensis with microsomal fraction associated with BCG.
    Goncalves da Costa S; Santos EB; Lagrange PH
    Ann Inst Pasteur Immunol; 1988; 139(2):143-56. PubMed ID: 3370128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Delayed hypersensitivity response in mice immunized with non-viable promastigotes of Leishmania mexicana].
    Pérez HA; de la Rosa M
    Rev Latinoam Microbiol; 1986; 28(1):39-46. PubMed ID: 3738284
    [No Abstract]   [Full Text] [Related]  

  • 40. Dissociation of delayed-type hypersensitivity from acquired murine resistance to Brucella suis.
    Escande A; Cannat A; Serre A
    Ann Immunol (Paris); 1980; 131D(2):199-204. PubMed ID: 7469385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.